References
- 1. Bernal W, Wendon J. Acute Liver Failure. N Engl J Med 2013; 369: 2525-34.
- 2. Blasco-Algora S, Masegosa-Ataz J, Gutiérrez-García ML, López SA, Fernández-Rodríguez CM. Acute-on-chronic liver failure: Pathogenesis, prognostic factors and management. World J Gastroenterol 2015; 21(42): 12125-40.
- 3. Olin P, Hausken J, Foss A, Karlsen TH, Melum E et Haugaa H. Continuous molecular adsorbent recirculating system treatment in 69 patients listed for liver transplantation. Scandinavian Journal of Gastroenterology. 2015; 50: 1127-34.
- 4. Krisper P, Stadlbauer V, Stauber RE. Clearing of toxic substances: are there differences between the available liver support devices? Liver Int 2011; 31: 5–8.10.1111/j.1478-3231.2011.02588.x
- 5. Faybik P, Krenn CG. Extracorporeal liver support. Curr Opin Crit Care 2013; 19: 149–53.10.1097/MCC.0b013e32835eb970
- 6. Banares R, Nevens F, Larsen FS, Jalan R, Albillos A, Dollinger M, et al. Extracorporeal albumin dialysis with the molecular adsorbence recirculating system in acute-onchronic liver failure: the RELIEF trial. Hepatology 2013; 57: 1153–62.
- 7. Cisneros-Garza LE, del Rosario Muñoz-Ramírez M, Muñoz-Espinoza LE, Ruiz Velasco JAV, Moreno-Alcántar R, Marín-López E. The molecular adsorbent recirculating system as a liver support system. Summary of Mexican experience. Ann Hepatol 2014; 13(2): 240-7.
- 8. Pares A, Deulofeu R, Cisneros L, Escorsell A, Salmeron JM, Caballeria J, et al. Albumin dialysis improves hepatic encephalopathy and decreases circulating phenolic aromatic amino acids in patients with alcoholic hepatitis and severe liver failure. Crit Care 2009; 13: R8.
- 9. Chiu A, Tsoi NS, Fan ST. Use of the molecular adsorbents recirculating system as a treatment for acute decompensated Wilson disease. Liver Transpl 2008; 14: 1512–16.
- 10. Trey C, Davidson CS. The management of fulminant hepatic failure. Prog Liver Dis 1970; 3: 282-98.
- 11. Wlodzimirow KA, Eslami S, Abu-Hanna A, Nieuwoudt M, Chamuleau RA. Systematic review: acute liver failure — one disease, more than 40 definitions. Aliment Pharmacol Ther 2012; 35: 1245-56.
- 12. Mochida S, Nakayama N, Matsui A, Nagoshi S, Fujiwara K. Re-evaluation of the Guideline published by the Acute Liver Failure Study Group of Japan in 1996 to determine the indications of liver transplantation in patients with fulminant hepatitis. Hepatol Res 2008; 38: 970-9.
- 13. Wai CT, Fontana RJ, Polson J, Hussain M, Shakil AO, Han SH, et al. Clinical outcome and virological characteristics of hepatitis B-related acute liver failure in the United States. J Viral Hepat 2005; 12(2): 192–8.
- 14. Brochard L, Abroug F, Brenner M et al. An Official ATS/ERS/ESICM/SCCM/SRLF Statement:Prevention and management of acute renal failure in the ICU patient: An international consensus conference in intensive care medicine. Am J Resp Crit Care Med 2010; 181: 1128-55.
- 15. Kelly JA, Lameire N and the KDIGO Work Group. KDIGO Clinical Practice Guideline for Acute kidney injury. Kidney International 2012; 2(1).
- 16. Wadei H, Mai M, Ahsan N, Gonwa T. Hepatorenal syndrome: patho-physiology andmanagement. Clin J Am Soc Nephrol 2006; 1: 1066-79.
- 17. Ferenci P, Lockwood A, Mullen K, et al. Hepatic encephalopathy: definition, nomenclature, diagnosis, and quantification. Hepatology 2002; 35: 716-21.10.1053/jhep.2002.31250
- 18. Schiodt FV, Ostapowicz G, Murray N et al. Alphafetoprotein and prognosis in acute liver failure. Liver Transplant 2006; 12: 1776-81.
- 19. Schmidt LE, Dalhoff K. Alpha-fetoprotein is a predictor of outcome in acetaminophen-induced liver injury. Hepatology 2005; 41: 26–31.10.1002/hep.20511
- 20. Kakisaka K, Kataoka K, Onodera M, Suzuki A, Endo K, Tatemichi Y et al. Alpha-fetoprotein: A biomarker for the recruitment of progenitor cells in the liver in patients with acute liver injury or failure, Hepatology Research 2015; 45(10): E12-E20.
- 21. Fausto N, Campbell JS, Riehle KJ. Liver regeneration. Hepatology 2006; 43: S45–53.
- 22. Sponholz C, Matthes K, Rupp D, Backaus W, Klammt S, Karailieva D et al. Molecular adsorbent recirculating system and single-pass albumin dialysis in liver failure – a prospective, randomised crossover study. Critical Care 2016; 20(1): 2